Ghrelin inhibits ovarian epithelial carcinoma cell proliferation in vitro

Xu,Yang; Pang,Xiaoyan; Dong,Mei; Wen,Fang; Zhang,Yi

doi:10.3892/or.2013.2692

Ghrelin inhibits ovarian epithelial carcinoma cell proliferation in vitro

Authors:
- Yang Xu
- Xiaoyan Pang
- Mei Dong
- Fang Wen
- Yi Zhang
View Affiliations

Affiliations: Department of Gynecology, the First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: August 23, 2013 https://doi.org/10.3892/or.2013.2692
Pages: 2063-2070

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The only orexigenic peptide, ghrelin, which is primarily produced by the gastrointestinal tract, has been implicated in malignant cell proliferation and invasion. Ghrelin is a natural ligand of the growth hormone secretagogue receptor 1a (GHSR1a). However, the role of ghrelin in ovarian epithelial carcinoma remains unknown since the expression of GHSR1a in ovary is not confirmed. The aim of the present study was to assess expression of ghrelin and its receptor in human ovarian epithelial carcinoma and to examine the effect of ghrelin on carcinoma cell proliferation. Frozen sections of ovarian samples and the human ovarian epithelial carcinoma cell line, HO-8910, were used to characterize the expression of ghrelin/GHSR1a axis and the effect of ghrelin on proliferation. We found that ghrelin and GHSR1a are expressed in ovarian epithelial carcinoma in vivo and in vitro. Ghrelin inhibits the proliferation and growth of HO-8910 cells by G1 phase arrest, and this inhibition may be abolished by the ghrelin receptor antagonist D-Lys-3-GH-releasing peptide-6 and ghrelin neutralizing antibody. Ghrelin enhances HO-8910 cell apoptosis and autophagy. The activation of mammalian target of rapamycin (mTOR) signaling pathway blocks the effects of ghrelin-induced autophagy and apoptosis, therefore reverses the inhibition of HO-8910 cell proliferation induced by ghrelin. In conclusion, the present study demonstrates that ghrelin inhibits the proliferation of human HO-8910 ovarian epithelial carcinoma cells by inducing apoptosis and autophagy via the mTOR signaling pathway. This study provides a novel regulatory signaling pathway of ghrelin-regulated ovarian epithelial carcinoma growth and may contribute to ovarian cancer prevention and therapy.

View Figures

View References

1	Billottet C, Janji B, Thiery JP and Jouanneau J: Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2. Oncogene. 21:8128–8139. 2002. View Article : Google Scholar : PubMed/NCBI
2	Di Blasio AM, Cremonesi L, Viganó P, et al: Basic fibroblast growth factor and its receptor messenger ribonucleic acids are expressed in human ovarian epithelial neoplasms. Am J Obstet Gynecol. 169:1517–1523. 1993.PubMed/NCBI
3	Chopin L, Walpole C, Seim I, et al: Ghrelin and cancer. Mol Cell Endocrinol. 340:65–69. 2011. View Article : Google Scholar : PubMed/NCBI
4	Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H and Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:656–660. 1999. View Article : Google Scholar : PubMed/NCBI
5	Kojima M and Kangawa K: Ghrelin: structure and function. Physiol Rev. 85:495–522. 2005. View Article : Google Scholar
6	Smith RG, Leonard R, Bailey AR, et al: Growth hormone secretagogue receptor family members and ligands. Endocrine. 14:9–14. 2001. View Article : Google Scholar : PubMed/NCBI
7	Majchrzak K, Szyszko K, Pawlowski KM, Motyl T and Król M: A role of ghrelin in cancerogenesis. Pol J Vet Sci. 15:189–197. 2012.PubMed/NCBI
8	Zhang W, Lin TR, Hu Y, et al: Ghrelin stimulates neurogenesis in the dorsal motor nucleus of the vagus. J Physiol. 559:729–737. 2004. View Article : Google Scholar : PubMed/NCBI
9	Kim SW, Her SJ, Park SJ, et al: Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells. Bone. 37:359–369. 2005. View Article : Google Scholar : PubMed/NCBI
10	De Vriese C and Delporte C: Autocrine proliferative effect of ghrelin on leukemic HL-60 and THP-1 cells. J Endocrinol. 192:199–205. 2007.PubMed/NCBI
11	Waseem T, Javaid-Ur-Rehman, Ahmad F, Azam M and Qureshi MA: Role of ghrelin axis in colorectal cancer: a novel association. Peptides. 29:1369–1376. 2008. View Article : Google Scholar : PubMed/NCBI
12	Ghè C, Cassoni P, Catapano F, et al: The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology. 143:484–491. 2002.PubMed/NCBI
13	Gnanapavan S, Kola B, Bustin SA, et al: The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 87:29882002. View Article : Google Scholar : PubMed/NCBI
14	Gomez-Pinillos A and Ferrari AC: mTOR signaling pathway and mTOR inhibitors in cancer therapy. Hematol Oncol Clin North Am. 26:483–505. 2012. View Article : Google Scholar : PubMed/NCBI
15	Lynch CJ: Role of leucine in the regulation of mTOR by amino acids: revelations from structure-activity studies. J Nutr. 131:861S–865S. 2001.PubMed/NCBI
16	Rosenfeldt MT and Ryan KM: The multiple roles of autophagy in cancer. Carcinogenesis. 32:955–963. 2011. View Article : Google Scholar : PubMed/NCBI
17	Mah LY and Ryan KM: Autophagy and cancer. Cold Spring Harb Perspect Biol. 4:a0088212012.PubMed/NCBI
18	Gaytan F, Morales C, Barreiro ML, et al: Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives, and ovarian tumors. J Clin Endocrinol Metab. 90:1798–1804. 2005. View Article : Google Scholar
19	Markowska A, Ziółkowska A, Jaszczyńska-Nowinka K, Madry R and Malendowicz LK: Elevated blood plasma concentrations of active ghrelin and obestatin in benign ovarian neoplasms and ovarian cancers. Eur J Gynaecol Oncol. 30:518–522. 2009.PubMed/NCBI
20	Gutierrez JA, Solenberg PJ, Perkins DR, et al: Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA. 105:6320–6325. 2008. View Article : Google Scholar : PubMed/NCBI
21	Yang J, Brown MS, Liang G, Grishin NV and Goldstein JL: Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 132:387–396. 2008. View Article : Google Scholar : PubMed/NCBI
22	Lim CT, Kola B, Grossman A and Korbonits M: The expression of ghrelin O-acyltransferase (GOAT) in human tissues. Endocr J. 58:707–710. 2011. View Article : Google Scholar : PubMed/NCBI
23	Zhang W, Chai B, Li JY, Wang H and Mulholland MW: Effect of des-acyl ghrelin on adiposity and glucose metabolism. Endocrinology. 149:4710–4716. 2008. View Article : Google Scholar : PubMed/NCBI
24	Hosoda H, Kojima M, Matsuo H and Kangawa K: Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun. 279:909–913. 2000. View Article : Google Scholar : PubMed/NCBI
25	Inoki K, Corradetti MN and Guan KL: Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet. 37:19–24. 2005. View Article : Google Scholar : PubMed/NCBI
26	Yang Q and Guan KL: Expanding mTOR signaling. Cell Res. 17:666–681. 2007. View Article : Google Scholar : PubMed/NCBI
27	Laplante M and Sabatini DM: mTOR signaling in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
28	LoRusso PM: Mammalian target of rapamycin as a rational therapeutic target for breast cancer treatment. Oncology. 84:43–56. 2013. View Article : Google Scholar : PubMed/NCBI
29	Fuchs Y and Steller H: Programmed cell death in animal development and disease. Cell. 147:742–758. 2011. View Article : Google Scholar : PubMed/NCBI
30	Bergmann A and Steller H: Apoptosis, stem cells, and tissue regeneration. Sci Signal. 3:re82010. View Article : Google Scholar : PubMed/NCBI
31	Meijer AJ: Amino acids as regulators and components of nonproteinogenic pathways. J Nutr. 133:2057S–2062S. 2003.PubMed/NCBI
32	Levine B and Klionsky DJ: Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell. 6:463–477. 2004. View Article : Google Scholar : PubMed/NCBI
33	Crighton D, Wilkinson S, O’Prey J, et al: DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell. 126:121–134. 2006. View Article : Google Scholar : PubMed/NCBI
34	Zhang H, Bosch-Marce M, Shimoda LA, et al: Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem. 283:10892–10903. 2008. View Article : Google Scholar : PubMed/NCBI
35	Jung CH, Ro SH, Cao J, Otto NM and Kim DH: mTOR regulation of autophagy. FEBS Lett. 584:1287–1295. 2010. View Article : Google Scholar : PubMed/NCBI
36	Chang YY, Juhász G, Goraksha-Hicks P, et al: Nutrient-dependent regulation of autophagy through the target of rapamycin pathway. Biochem Soc Trans. 37:232–236. 2009. View Article : Google Scholar : PubMed/NCBI